Edesa Biotech(EDSA) - 2024 Q2 - Quarterly Results

EX-99.1 2 edsa_ex991.htm PRESS RELEASE Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results TORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provided an update on its business. During the quarter, the company expanded site selection activities for a Phase 3 study of its ...